Capstone Financial Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History

Capstone Financial Advisors’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,500	Closed	-$310K	–	147
2022 Q4	$310K	Hold	11,500	–	–	0.03%	96
2022 Q3	$207K	Hold	11,500	–	–	0.02%	112
2022 Q2	$143K	Hold	11,500	–	–	0.01%	114
2022 Q1	$153K	Hold	11,500	–	–	0.01%	120
2021 Q4	$179K	Hold	11,500	–	–	0.01%	124
2021 Q3	$258K	Hold	11,500	–	–	0.02%	108
2021 Q2	$262K	Hold	11,500	–	–	0.02%	106
2021 Q1	$237K	Hold	11,500	–	–	0.02%	101
2020 Q4	$318K	Hold	11,500	–	–	0.03%	78
2020 Q3	$162K	Hold	11,500	–	–	0.02%	98
2020 Q2	$237K	Buy	+11,500	New	+$156K	0.03%	81

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Capstone Financial Advisors's MYOV Position: Q1 2023 in Review

Capstone Financial Advisors sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 11,500 shares — an estimated $310K sold.

Capstone Financial Advisors first reported a position in MYOV in Q2 2020 and held it in 11 quarters. The position peaked at $318K in Q4 2020. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Capstone Financial Advisors reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Capstone Financial Advisors sold 11,500 Myovant Sciences Ltd. shares in Q1 2023, an estimated $310K.
Capstone Financial Advisors first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 11 quarters.
Capstone Financial Advisors's Myovant Sciences Ltd. position peaked at $318K in Q4 2020.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Capstone Financial Advisors's 13F filing for Q1 2023, filed 12 May 2023.